From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Press Release Launching Expanded Access Navigator
Dateline: Washington, D.C. The Reagan-Udall Foundation for the FDA launches Navigator website to share resources and policies on expanded access to investigational therapies.
Forbes article explains how the Navigator helps doctors request expanded access
Saving time is critical for physicians treating seriously ill patients who have exhausted alternatives to expanded access.
STAT features Navigator article by Exec. Dir. June Wasser
In the article, Wasser explains why the FDA asked its foundation to create a public-pri
MedPage Today describes the Navigator's 8 steps for expanded access
This short MedPage article focuses on th
DIA Global Forum article traces roots of IMEDS
Executive Director June Wasser
Denver Post notes Navigator as an FDA improvement in article about Right-To-Try
The Post and other publications picked up CQ-Roll Call's Andrew Siddons' analysis of the potential impact of federal Right-To-Try legislation.
FDA Blog kicks off industry coverage of Navigator launch
Susan G. Komen calls Navigator a lifeline
In this article, Interim President and CEO Ellen Willmot shares her hope that the Navigator will make it easier for breast cancer physicians and patients to apply for, and benefit from, expanded access to investigational t
Navigator's Oncology Focus Cited by ASCO
The American Society of Clinical Oncology helped develop the Navigator and in this post describes it as a clearinghouse for the single-patient exp
The Health Care Blog Shares Uses for Navigator
This post points out that the Navigator will expand from an oncology focus to other thera